Business · 11/06/2010
FDA Announces Plan to Index Medical Product Indications in Product Labeling
The FDA's Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research are seeking public input on their plan to index medical product indications in product labeling, a move that follows the agency's previous prioritization of pharmacologic class indexing.
Original source language: Federal Register — Health and Human ServicesOpen original release →